p53 gene mutational rate, Gleason score, and BK virus infection in prostate adenocarcinoma: Is there a correlation?

Prostate cancer represents the second leading cause of cancer deaths in Western countries. Viral infections could play a role in prostate carcinogenesis. Human polyomavirus BK (BKV) is a possible candidate because of its transforming properties. In this study, BKV sequences in urine, blood, fresh, and paraffin‐embedded prostate cancer samples from 26 patients were searched using Q‐PCR analysis. T antigen (TAg) and p53 localization in neoplastic cells were evaluated by immunohistochemical analysis. Also, the presence of mutations in 5–9 exons of p53 gene was analyzed. Results showed that BKV‐DNA was found in urine (54%), plasma (31%), and in fresh prostate cancer specimens (85%). The analysis of p53 gene evidenced several mutations in high Gleason patients, according to tumor advanced stage. Immunohistochemical analysis results evidenced the localization of p53 and TAg into cytoplasm, whereas in TAg‐negative tumors, p53 was nuclear. This study suggests that BKV acts as cofactor in the pathogenesis of prostate cancer. These observations emphasize previous studies regarding the cellular pathways that may be deregulated by BKV. J. Med. Virol. 80:2100–2107, 2008. © 2008 Wiley‐Liss, Inc.

[1]  Dweepanita Das,et al.  BK Virus as a Cofactor in the Etiology of Prostate Cancer in Its Early Stages , 2007, Journal of Virology.

[2]  A. Joachimiak,et al.  Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor. , 2006, Genes & development.

[3]  K. Khalili,et al.  Interaction of retinoblastoma protein family members with large T-antigen of primate polyomaviruses , 2006, Oncogene.

[4]  D. Burstein,et al.  Polyoma virus infection is a prominent risk factor for bladder carcinoma in immunocompetent individuals , 2006, Diagnostic cytopathology.

[5]  W. Atwood,et al.  The human polyomaviruses , 2006, Cellular and Molecular Life Sciences CMLS.

[6]  Jin-Tang Dong.  Prevalent mutations in prostate cancer , 2006, Journal of cellular biochemistry.

[7]  A. Giordano,et al.  The human polyomavirus BK: Potential role in cancer , 2005, Journal of cellular physiology.

[8]  O. Sheils,et al.  Molecular pathology of prostate cancer , 2005, Journal of Clinical Pathology.

[9]  R. Shah,et al.  Detection and expression of human BK virus sequences in neoplastic prostate tissues , 2004, Oncogene.

[10]  K. Khalili,et al.  Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis. , 2004, Virology.

[11]  David L Rimm,et al.  Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements. , 2004, The American journal of pathology.

[12]  M. Negrini,et al.  Oncogenic transformation by BK virus and association with human tumors , 2003, Oncogene.

[13]  Manuel Sánchez-Chapado,et al.  Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: An autopsy study , 2003, The Prostate.

[14]  L. Villarreal,et al.  Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections , 2002, The Prostate.

[15]  S. Dhanasekaran,et al.  The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.

[16]  W. Westra,et al.  Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. , 2002, Transplantation.

[17]  K. Khalili,et al.  Human Polyomaviruses: Molecular and Clinical Perspectives , 2002 .

[18]  M. Imperiale.  Oncogenic transformation by the human polyomaviruses , 2001, Oncogene.

[19]  D. Clifford,et al.  Bk virus: a clinical review. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  M. Shen,et al.  Molecular genetics of prostate cancer. , 2000, Genes & development.

[21]  M. Imperiale.  The human polyomaviruses, BKV and JCV: molecular pathogenesis of acute disease and potential role in cancer. , 2000, Virology.

[22]  P. Monini,et al.  DNA rearrangements impairing BK virus productive infection in urinary tract tumors. , 1995, Virology.

[23]  D. Coleman,et al.  New human papovavirus (B.K.) isolated from urine after renal transplantation. , 1971, Lancet.

[24]  E. Langhoff,et al.  Polyomavirus in human cancer development. , 2006, Advances in experimental medicine and biology.

[25]  J. Dillner,et al.  Serological diagnosis of human polyomavirus infection. , 2006, Advances in experimental medicine and biology.

[26]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[27]  A. Markham,et al.  Molecular biology of prostate cancer , 2004, Prostate Cancer and Prostatic Diseases.

[28]  S. Günther,et al.  Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. , 1994, Virology.